Copyright Reports & Markets. All rights reserved.

USA Clinical Next-Generation Sequencing Market Assessment 2020-2026

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Clinical Next-Generation Sequencing Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Targeted Sequencing Market Performance (Volume)
      • 2.1.2 Exome Sequencing Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 Targeted Sequencing Market Performance (Value)
      • 2.2.2 Exome Sequencing Market Performance (Value)

    3 Market Assessment by Application

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Hospitals and Clinics Market Performance (Volume)
      • 3.1.2 Biopharma Companies Market Performance (Volume)
      • 3.1.3 Academic and Research Organizations Market Performance (Volume)
      • 3.1.4 Others Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Thermo Fisher Scientific
      • 4.1.1 Thermo Fisher Scientific Profiles
      • 4.1.2 Thermo Fisher Scientific Product Information
      • 4.1.3 Thermo Fisher Scientific Clinical Next-Generation Sequencing Business Performance
      • 4.1.4 Thermo Fisher Scientific Clinical Next-Generation Sequencing Business Development and Market Status
    • 4.2 PerkinElmer
      • 4.2.1 PerkinElmer Profiles
      • 4.2.2 PerkinElmer Product Information
      • 4.2.3 PerkinElmer Clinical Next-Generation Sequencing Business Performance
      • 4.2.4 PerkinElmer Clinical Next-Generation Sequencing Business Development and Market Status
    • 4.3 Illumina
      • 4.3.1 Illumina Profiles
      • 4.3.2 Illumina Product Information
      • 4.3.3 Illumina Clinical Next-Generation Sequencing Business Performance
      • 4.3.4 Illumina Clinical Next-Generation Sequencing Business Development and Market Status
    • 4.4 Beckman Coulter
      • 4.4.1 Beckman Coulter Profiles
      • 4.4.2 Beckman Coulter Product Information
      • 4.4.3 Beckman Coulter Clinical Next-Generation Sequencing Business Performance
      • 4.4.4 Beckman Coulter Clinical Next-Generation Sequencing Business Development and Market Status
    • 4.5 GATC Biotech
      • 4.5.1 GATC Biotech Profiles
      • 4.5.2 GATC Biotech Product Information
      • 4.5.3 GATC Biotech Clinical Next-Generation Sequencing Business Performance
      • 4.5.4 GATC Biotech Clinical Next-Generation Sequencing Business Development and Market Status
    • 4.6 Qiagen
      • 4.6.1 Qiagen Profiles
      • 4.6.2 Qiagen Product Information
      • 4.6.3 Qiagen Clinical Next-Generation Sequencing Business Performance
      • 4.6.4 Qiagen Clinical Next-Generation Sequencing Business Development and Market Status
    • 4.7 Roche
      • 4.7.1 Roche Profiles
      • 4.7.2 Roche Product Information
      • 4.7.3 Roche Clinical Next-Generation Sequencing Business Performance
      • 4.7.4 Roche Clinical Next-Generation Sequencing Business Development and Market Status
    • 4.8 Pacific Bioscience
      • 4.8.1 Pacific Bioscience Profiles
      • 4.8.2 Pacific Bioscience Product Information
      • 4.8.3 Pacific Bioscience Clinical Next-Generation Sequencing Business Performance
      • 4.8.4 Pacific Bioscience Clinical Next-Generation Sequencing Business Development and Market Status
    • 4.9 Agilent Technologies
      • 4.9.1 Agilent Technologies Profiles
      • 4.9.2 Agilent Technologies Product Information
      • 4.9.3 Agilent Technologies Clinical Next-Generation Sequencing Business Performance
      • 4.9.4 Agilent Technologies Clinical Next-Generation Sequencing Business Development and Market Status
    • 4.10 Macrogen
      • 4.10.1 Macrogen Profiles
      • 4.10.2 Macrogen Product Information
      • 4.10.3 Macrogen Clinical Next-Generation Sequencing Business Performance
      • 4.10.4 Macrogen Clinical Next-Generation Sequencing Business Development and Market Status
    • 4.11 Oxford Nanopore
    • 4.12 Foundation Medicine
    • 4.13 Life technologies
    • 4.14 Exosome Diagnostics
    • 4.15 CLC Bio
    • 4.16 Paradigm
    • 4.17 Partek
    • 4.18 GnuBIO
    • 4.19 Caris Life Sciences
    • 4.20 Macrogen

    5 Market Performance for Manufacturers

    • 5.1 USA Clinical Next-Generation Sequencing Sales (K Units) and Market Share by Manufacturers (2014-2020)
    • 5.2 USA Clinical Next-Generation Sequencing Revenue (M USD) and Market Share by Manufacturers (2014-2020)
    • 5.3 USA Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
    • 5.4 USA Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Northeast Market Performance for Manufacturers
      • 6.1.1 Northeast Clinical Next-Generation Sequencing Sales (K Units) and Share of Manufacturers (2014-2020)
      • 6.1.2 Northeast Clinical Next-Generation Sequencing Revenue (M USD) and Share of Manufacturers (2014-2020)
      • 6.1.3 Northeast Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
      • 6.1.4 Northeast Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
      • 6.1.5 Market Concentration
    • 6.2 Midwest Market Performance for Manufacturers
      • 6.2.1 Midwest Clinical Next-Generation Sequencing Sales (K Units) and Share of Manufacturers (2014-2020)
      • 6.2.2 Midwest Clinical Next-Generation Sequencing Revenue (M USD) and Share of Manufacturers (2014-2020)
      • 6.2.3 Midwest Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
      • 6.2.4 Midwest Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
      • 6.2.5 Market Concentration
    • 6.3 South Market Performance for Manufacturers
      • 6.3.1 South Clinical Next-Generation Sequencing Sales (K Units) and Share of Manufacturers (2014-2020)
      • 6.3.2 South Clinical Next-Generation Sequencing Revenue (M USD) and Share of Manufacturers (2014-2020)
      • 6.3.3 South Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
      • 6.3.4 South Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
      • 6.3.5 Market Concentration
    • 6.4 West Market Performance for Manufacturers
      • 6.4.1 West Clinical Next-Generation Sequencing Sales (K Units) and Share of Manufacturers (2014-2020)
      • 6.4.2 West Clinical Next-Generation Sequencing Revenue (M USD) and Share of Manufacturers (2014-2020)
      • 6.4.3 West Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
      • 6.4.4 West Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
      • 6.4.5 Market Concentration

    7 USA Clinical Next-Generation Sequencing Market Performance (Sales Point)

    • 7.1 USA Clinical Next-Generation Sequencing Sales (K Units) and Market Share by Regions (2014-2020)
    • 7.2 USA Clinical Next-Generation Sequencing Revenue (M USD) and Market Share by Regions (2014-2020)
    • 7.3 USA Clinical Next-Generation Sequencing Price (USD/Unit) by Regions (2014-2020)
    • 7.4 USA Clinical Next-Generation Sequencing Gross Margin by Regions (2014-2020)

    8 Development Trend for Regions (Sales Point)

    • 8.1 USA Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate(2014-2020)
    • 8.2 Northeast Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate(2014-2020)
    • 8.3 Midwest Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate(2014-2020)
    • 8.4 South Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate(2014-2020)
    • 8.5 West Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate(2014-2020)

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Hospitals and Clinics Industry
    • 11.2 Biopharma Companies Industry
    • 11.3 Academic and Research Organizations Industry

    12 Market Forecast 2021-2026

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
      • 12.1.1 USA Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
      • 12.1.2 USA Clinical Next-Generation Sequencing Sales (K Units) and Growth Rate 2021-2026
      • 12.1.3 Northeast Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.4 Midwest Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.5 South Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.6 West Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.7 Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.8 Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.9 Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.10 Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2021-2026
      • 12.3.1 Overall Market Performance
      • 12.3.2 Targeted Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.3.3 Exome Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.4 Sales by Application 2021-2026
      • 12.4.1 Overall Market Performance
      • 12.4.2 Hospitals and Clinics Sales and and Growth Rate 2021-2026
      • 12.4.3 Biopharma Companies Sales and and Growth Rate 2021-2026
      • 12.4.4 Academic and Research Organizations Sales and and Growth Rate 2021-2026
      • 12.4.5 Others Sales and and Growth Rate 2021-2026
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 USA Clinical Next-Generation Sequencing Price (USD/Unit) Trend 2021-2026
      • 12.5.2 USA Clinical Next-Generation Sequencing Gross Profit Trend 2021-2026

    13 Conclusion

    In this report, our team research the USA Clinical Next-Generation Sequencing market by type, application, region and manufacturer (2014-2020) and forcast 2021-2026. For the region, type and application, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.

    Geographically, this report split USA into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Clinical Next-Generation Sequencing for these regions, from 2014 to 2026 (forecast), including
    Northeast
    Midwest
    South
    West

    USA Clinical Next-Generation Sequencing market competition by top manufacturers/players, with Clinical Next-Generation Sequencing sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Thermo Fisher Scientific
    PerkinElmer
    Illumina
    Beckman Coulter
    GATC Biotech
    Qiagen
    Roche
    Pacific Bioscience
    Agilent Technologies
    Macrogen
    Oxford Nanopore
    Foundation Medicine
    Life technologies
    Exosome Diagnostics
    CLC Bio
    Paradigm
    Partek
    GnuBIO
    Caris Life Sciences
    Others

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Targeted Sequencing
    Exome Sequencing

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Clinical Next-Generation Sequencing for each application, including
    Hospitals and Clinics
    Biopharma Companies
    Academic and Research Organizations
    Others

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now